{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:04:18Z","timestamp":1791097458582,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/inf.0b013e318292f560","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T14:24:07Z","timestamp":1364480647000},"page":"933-936","source":"Crossref","is-referenced-by-count":30,"title":["Intravenous Pentamidine Is Safe and Effective as Primary Pneumocystis Pneumonia Prophylaxis in Children and Adolescents Undergoing Hematopoietic Stem Cell Transplantation"],"prefix":"10.1097","volume":"32","author":[{"given":"James M.","family":"DeMasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Y.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/eri.10.42","article-title":"Pneumocystis infection in humans: diagnosis and treatment.","volume":"8","author":"Calderon","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0031-1295725","article-title":"Pneumocystis pneumonia.","volume":"32","author":"Gilroy","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1001\/jama.2009.880","article-title":"Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment.","volume":"301","author":"Kovacs","year":"2009","journal-title":"JAMA"},{"key":"R4-4-20210202","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome.","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R5-4-20210202","first-page":"267","article-title":"Pneumocystis carinii pneumonitis following bone marrow transplantation.","volume":"10","author":"Tuan","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"R6-4-20210202","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1705149","article-title":"Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study.","volume":"36","author":"De Castro","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R7-4-20210202","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/pbc.21287","article-title":"Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.","volume":"50","author":"Kim","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R8-4-20210202","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1542\/peds.2006-1360","article-title":"Successful intermittent prophylaxis with trimethoprimsulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients.","volume":"120","author":"Lindemulder","year":"2007","journal-title":"Pediatrics"},{"key":"R9-4-20210202","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/0003-4819-112-10-750","article-title":"Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia.","volume":"112","author":"Jules-Elysee","year":"1990","journal-title":"Ann Intern Med"},{"key":"R10-4-20210202","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/pbc.20840","article-title":"Failure of intravenous pentamidine prophylaxis to prevent pneumocystis pneumonia in a pediatric hematopoietic stem cell transplant (HSCT) patient.","volume":"47","author":"Milstone","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/oxfordjournals.aje.a115507","article-title":"A simple method to calculate the confidence interval of a standardized mortality ratio (SMR).","volume":"131","author":"Ulm","year":"1990","journal-title":"Am J Epidemiol"},{"key":"R12-4-20210202","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","article-title":"S.); Infectious Diseases Society of America; American Society of Blood and Marrow Transplantation. . Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.","volume":"33","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R13-4-20210202","first-page":"403","article-title":"Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT.","volume":"11","author":"Link","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","article-title":"Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis.","volume":"316","author":"Hughes","year":"1987","journal-title":"N Engl J Med"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1399-3062.2002.t01-1-00008.x","article-title":"Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation.","volume":"4","author":"Marras","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"R16-4-20210202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1083-8791(00)70050-4","article-title":"Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.","volume":"6","author":"Vasconcelles","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.1994.12.2.258","article-title":"Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprimsulfamethoxazole.","volume":"12","author":"Mustafa","year":"1994","journal-title":"J Clin Oncol"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ppul.1950180406","article-title":"The use of aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in children with leukemia.","volume":"18","author":"OSullivan","year":"1994","journal-title":"Pediatr Pulmonol"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.1994.12.1.136","article-title":"Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia.","volume":"12","author":"Weinthal","year":"1994","journal-title":"J Clin Oncol"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJM199305273282102","article-title":"Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection.","volume":"328","author":"Girard","year":"1993","journal-title":"N Engl J Med"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/313509","article-title":"High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis.","volume":"29","author":"Souza","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/314893","article-title":"Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.","volume":"180","author":"Chan","year":"1999","journal-title":"J Infect Dis"},{"key":"R23-4-20210202","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1702004","article-title":"A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprimsulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.","volume":"24","author":"Colby","year":"1999","journal-title":"Bone Marrow Transplant"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e318292f560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:10:49Z","timestamp":1620954649000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201309000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318292f560","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}